ELDTAM

Main information

  • Trade name:
  • ELDTAM 10 TAB
  • Dosage:
  • 10MG
  • Pharmaceutical form:
  • TAB
  • Composition:
  • 10
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ELDTAM 10 TAB
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

29-6-2017

Orphan designation:  Tamoxifen citrate,  for the: Treatment of cystic fibrosis

Orphan designation: Tamoxifen citrate, for the: Treatment of cystic fibrosis

Europe - EMA - European Medicines Agency

12-3-2018

TAMOXIFEN CITRATE Tablet, Film Coated [McKesson Corporation]

TAMOXIFEN CITRATE Tablet, Film Coated [McKesson Corporation]

Updated Date: Mar 12, 2018 EST

US - DailyMed

7-3-2018

TAMOXIFEN CITRATE Tablet [Bryant Ranch Prepack]

TAMOXIFEN CITRATE Tablet [Bryant Ranch Prepack]

Updated Date: Mar 7, 2018 EST

US - DailyMed

20-2-2018

TAMOXIFEN CITRATE Tablet [Proficient Rx LP]

TAMOXIFEN CITRATE Tablet [Proficient Rx LP]

Updated Date: Feb 20, 2018 EST

US - DailyMed

31-1-2018

TAMOXIFEN CITRATE Tablet, Film Coated [Mayne Pharma Inc.]

TAMOXIFEN CITRATE Tablet, Film Coated [Mayne Pharma Inc.]

Updated Date: Jan 31, 2018 EST

US - DailyMed

23-1-2018

TAMOXIFEN CITRATE Tablet [Mylan Pharmaceuticals Inc.]

TAMOXIFEN CITRATE Tablet [Mylan Pharmaceuticals Inc.]

Updated Date: Jan 23, 2018 EST

US - DailyMed

3-1-2018

TAMOXIFEN CITRATE Tablet, Film Coated [Bryant Ranch Prepack]

TAMOXIFEN CITRATE Tablet, Film Coated [Bryant Ranch Prepack]

Updated Date: Jan 3, 2018 EST

US - DailyMed

3-1-2018

TAMOXIFEN CITRATE Tablet, Film Coated [Cadila Healthcare Limited]

TAMOXIFEN CITRATE Tablet, Film Coated [Cadila Healthcare Limited]

Updated Date: Jan 3, 2018 EST

US - DailyMed

3-1-2018

TAMOXIFEN CITRATE Tablet, Film Coated [Zydus Pharmaceuticals (USA) Inc.]

TAMOXIFEN CITRATE Tablet, Film Coated [Zydus Pharmaceuticals (USA) Inc.]

Updated Date: Jan 3, 2018 EST

US - DailyMed

6-12-2017

Arimidex vs. Femara

Arimidex vs. Femara

Arimidex (anastrozole) and Femara (letrozole) are non-steroidal aromatase inhibitors (lowers estrogen production) used to treat breast cancer in postmenopausal women. Arimidex and Femara are often given to women whose cancer has progressed even after taking tamoxifen (Nolvadex, Soltamox) for some time.

US - RxList

29-11-2017

SOLTAMOX (Tamoxifen Citrate) Liquid [Midatech Pharma US Inc.]

SOLTAMOX (Tamoxifen Citrate) Liquid [Midatech Pharma US Inc.]

Updated Date: Nov 29, 2017 EST

US - DailyMed

10-11-2017

EU/3/17/1944 (Duchenne UK)

EU/3/17/1944 (Duchenne UK)

EU/3/17/1944 (Active substance: Tamoxifen citrate) - Orphan designation - Commission Decision (2017)7566 of Fri, 10 Nov 2017 European Medicines Agency (EMA) procedure number: EMA/OD/133/17

Europe -DG Health and Food Safety

25-10-2017

Tamoxifen

Tamoxifen

Tamoxifen is used to treat breast cancer that has spread to other parts of the body (metastatic breast cancer), to treat breast cancer in certain patients after surgery and radiation therapy, and to reduce the chances of breast cancer in high-risk patients.

US - RxList

16-10-2017

TAMOXIFEN CITRATE Tablet [A-S Medication Solutions]

TAMOXIFEN CITRATE Tablet [A-S Medication Solutions]

Updated Date: Oct 16, 2017 EST

US - DailyMed

16-8-2017

Exemestane

Exemestane

Exemestane is an antineoplastic (anticancer) agent used to treat breast cancer in postmenopausal women. Exemestane is often given to women whose cancer has progressed even after taking tamoxifen (Nolvadex, Soltamox) for 2 to 3 years.

US - RxList

26-7-2017

TAMOXIFEN CITRATE Tablet [Mayne Pharma Inc.]

TAMOXIFEN CITRATE Tablet [Mayne Pharma Inc.]

Updated Date: Jul 26, 2017 EST

US - DailyMed

23-5-2017

EU/3/17/1877 (GB Pharma Srl)

EU/3/17/1877 (GB Pharma Srl)

EU/3/17/1877 (Active substance: Tamoxifen citrate) - Orphan designation - Commission Decision (2017)3610 of Tue, 23 May 2017 European Medicines Agency (EMA) procedure number: EMA/OD/006/17

Europe -DG Health and Food Safety